Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

FAP inflammation imaging narrows in on osteoarthritis

SPECT and PET can detect the pathology of chronic joint pain due to rheumatoid arthritis when performed with agents that target antifibroblast activation protein (FAP) antibodies, according to a study presented last week during the 2014 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in St. Louis.

Thumbnail

Peptide receptor chemo-radionuclide therapy trips up more NETs

Chemo and radionuclide therapy together with the addition of drugs that make patients more radiosensitive have been shown to diminish and even suppress neuroendeocrine tumors (NETs) from progressing in 70 percent of cases. As a result, peptide receptor chemo-radionuclide therapy may offer patients improved survival rates, according to a study presented at the recent Society of Nuclear Medicine and Molecular Imaging 2014 Annual Meeting held June 7-11 in St. Louis.

SPECT/CT spots source of low back pain

Back pain is a burden for most people at some point in their lifetime, but pinpointing the reason for the pain can be tricky. Researchers presenting during the recent Society of Nuclear Medicine and Molecular Imaging 2014 Annual Meeting in St. Louis have found that SPECT/CT in addition to conventional bone scan gets straight to the point of pain, leading to much higher pain relief following intervention.

ASTRO and AAPM announce RO-ILS: Radiation Oncology Incident Learning System (RO-ILS)

Together, the American Society for Radiation Oncology (ASTRO) and the American Association of Physicists in Medicine (AAPM) will share details about RO-ILS: Radiation Oncology Incident Learning System, a new, national patient safety initiative to facilitate safer and higher quality radiation oncology care.

Personalized care from disease detection through treatment assessment enabled with GE Healthcare’s Discovery IQ

During the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE Healthcare introduced its Discovery IQ PET/CT system, enabling both outstanding image quality and intelligent quantitation, helping physicians deliver the best possible patient outcomes.

Thumbnail

Lymphoseek: Newly approved for oral cavity cancer, more expansion expected

Lymphoseek, otherwise known as technetium Tc-99m tilmanocept, is now available for use in sentinel lymph-node mapping of patients with cases of head and neck cancer. Producer Navidea Biopharmaceuticals, based in Dublin, Ohio, held a teleconference for stakeholders yesterday to discuss the expanded approval.

NorthStar Medical teams with Triad for domestic supply of moly

NorthStar Medical Radioisotopes, based in Madison, Wis., announced a non-exclusive letter of intent yesterday with major radiopharmacy chain Triad Isotopes in an effort to provide a U.S. source of molybdenum-99 (Mo-99), which decays to produce technetium-99m (Tc-99m), used in the lion's share of nuclear medicine procedures.

FDA approves Lymphoseek to help determine the extent of head and neck cancer in the body

The U.S. Food and Drug Administration today approved a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent used to help doctors determine the extent a type of cancer called squamous cell carcinoma has spread in the body’s head and neck region.